News

Forward Health, the app working to reinvent healthcare communication, has today announced a $3.9M seed funding-round led by Stride.VC , with additional backing from AlbionVC . The funds are joined by an impressive roster of angel backers, including healthtech founders Jay Desai from US company Patient Ping and Melissa Morris from UK-based Lantum.

Forward was founded in 2016 by UK doctors Barney Gilbert and Lydia Yarlott, alongside serial entrepreneur Philip Mundy. Their mission is to connect healthcare systems around the world, making…

UCLTF funded Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $150 million Series C financing.

Deerfield Management led the financing with significant new investments from RA Capital Management, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management LP, ArrowMark Partners, Sphera Global Healthcare, Medison Ventures, Driehaus Capital Management and Ghost Tree Capital Group,…

UCLH Cancer Collaborative has today launched the first pilot project of an NHS ovarian cancer surveillance service for women who carry a faulty BRCA gene and have chosen not to have their ovaries and fallopian tubes removed.

The pilot, known as the ALDO project (Avoiding Late Diagnosis in Ovarian Cancer), aims to recruit 2,000 women aged over 35 from across England [1] and will use Abcodia’s ROCA© Test as part of an NHS service to detect ovarian cancer amongst BRCA-carriers before they have any symptoms. The ROCA Test uses an algorithm to…

Funding led by the UCL Technology Fund with participation from: Nationwide Building Society, Pentland, Amadeus Capital Partners and AI Seed

Hazy, the London-based AI company enabling ethical, effortless and GDPR-compliant data sharing for responsible businesses, has announced an additional $1.8 million seed funding led by UCL Technology Fund, alongside Nationwide Building Society, Pentland, Amadeus Capital Partners, AI Seed and other investors.

This takes Hazy’s total seed funding to $2.8 million following a $1 million investment from…

Albion participated in the round, led by Dawn Capital, with return backers HSBC also participating. The new funding will be used to further develop Quantexa’s unique technology and support its international expansion.

The investment follows continued success this year as the firm announced partnerships with Deloitte and HSBC to help prevent money-laundering activity and improving customer insight with Shell.

British Patient Capital, the new wholly-owned commercial subsidiary of the British Business Bank, is an investor in Dawn…

Phrasee, the London-headquartered marketing technology company that uses artificial intelligence (AI) to generate optimised marketing copy, has closed a $4m Series A funding round. The investment will fuel Phrasee’s international growth plans, including scaling up its new US operation in San Francisco and the recently announced expansion of its UK team.

Albion led the round, with follow-on funds from existing investors including global digital communications business Next Fifteen PLC (Next 15) and angel syndicate Galvanise Capital. Next 15…

uMotif, the data capture company putting patients at the centre of clinical research, has raised £2.4 million in its latest funding round led by Albion along with several angel investors.

uMotif’s software platform provides the patient-facing technology required to capture real-world data (eCOA, ePRo, eConsent) for the next generation of clinical research initiatives – from early phase to post-marketing trials. The technology is already in use by top pharma companies across Europe and North America, including AstraZeneca, Novartis and UCB…

The UCL Technology Fund is very proud to have backed BloomsburyAI and we are delighted that they are joining Facebook team in London.  

For the full story please visit https://lnkd.in/eiX6Zsy